4-(4-benzylpiperazin-1-yl)-2-ethyl-10h-thieno[2,3-b][1,5]benzodiazepine (CHEM335359)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-08-30 22:47:14 UTC | ||||||||
| Update Date | 2026-08-30 22:47:14 UTC | ||||||||
| Accession Number | CHEM335359 | ||||||||
| Identification | |||||||||
| Common Name | 4-(4-benzylpiperazin-1-yl)-2-ethyl-10h-thieno[2,3-b][1,5]benzodiazepine | ||||||||
| Class | Small Molecule | ||||||||
| Description | Not Available | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C24H26N4S | ||||||||
| Average Molecular Mass | Not Available | ||||||||
| Monoisotopic Mass | 402.188 g/mol | ||||||||
| CAS Registry Number | Not Available | ||||||||
| IUPAC Name | Not Available | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CCC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)CC5=CC=CC=C5 | ||||||||
| InChI Identifier | InChI=1S/C24H26N4S/c1-2-19-16-20-23(25-21-10-6-7-11-22(21)26-24(20)29-19)28-14-12-27(13-15-28)17-18-8-4-3-5-9-18/h3-11,16,26H,2,12-15,17H2,1H3 | ||||||||
| InChI Key | ZCPKIRAPTGPJLK-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra | |||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
